The evolution of precision healthcare is undergoing a structural shift. Historically, clinical practice relied on static diagnostic categorisations, classifying patients according to cross-sectional clinical presentations and isolated tissue pathologies. However, the integration of high-throughput sequencing, multi-omics profiling and advanced artificial intelligence (AI) is reframing human health as a dynamic, non-linear continuum

Nelson Advisors interviewed by Mergermarket: Big Pharma, Big Tech target genomics players to feed AI models with healthcare data.